Cargando…
Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
Gastric and gastroesophageal junction (GEJ) cancer is one of the most common malignancy worldwide. In unresectable or metastatic disease, the prognosis is poor and is generally less than a year. Standard front-line chemotherapy includes two- or three-drug regimens with the addition of trastuzumab in...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575962/ https://www.ncbi.nlm.nih.gov/pubmed/33145328 http://dx.doi.org/10.21037/atm-20-1159 |